drugset / Trial / NCT03922048
Pediatric Postoperative Analgesia Herniorrhaphy Study
RandomizedSequentialTriple-blindTreatment
Summary
This is a Phase 2 study in pediatric subjects undergoing inguinal herniorrhaphy.
Timeline
- Start
- 2023-07
- Primary completion
- 2025-11
- Completion
- 2025-12
Outcome
Outcome not reported
Stopped (Enrollment): “Withdrawn due to lack of enrollment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Subject | HTX-011 | Unknown | 0.17 unknown | Other |
Indications
No indication recorded.